CEPHALOTHIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cephalothin Sodium patents expire, and when can generic versions of Cephalothin Sodium launch?
Cephalothin Sodium is a drug marketed by Abbott, Abraxis Pharm, Bristol, and Baxter Hlthcare. and is included in six NDAs.
The generic ingredient in CEPHALOTHIN SODIUM is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for CEPHALOTHIN SODIUM
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 2 |
Patent Applications: | 996 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEPHALOTHIN SODIUM at DailyMed |
Recent Clinical Trials for CEPHALOTHIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Instituto Mexicano del Seguro Social | Phase 3 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |